Moffitt Cancer Center

Today at #SNO2024, join these experts for the poster session to learn more about their work! Society for Neuro-Oncology ? 11/22 from 7:30 - 9:30 p.m. CST in Hall B3 Catherine Boldig, DO presents a case of hyperbaric oxygen used as a treatment modality for anaplastic astrocytoma. This case concludes that hyperbaric oxygen combined with other treatment modalities may be a promising therapy to improve quality of life. ?? Poster 538 https://lnkd.in/evMcXXRn Catherine Boldig, DO presents a case of metastatic glioblastoma. This case concludes that genetic aberrations such as high copy number and tumor mutational burden have been postulated as facilitators of metastatic potential. ?? Poster 707 https://lnkd.in/e-X2jHjH Adolfo Baez, MD discusses how disseminated Cryptococcus neoformans can mimick the central nervous system progression of diffuse large B-cell lymphoma. This case highlights the risk of opportunistic infections like disseminated Cryptococcus neoformans in immunocompromised patients. ?? Poster 1289 https://lnkd.in/e-9eSfeE Sepideh Mokhtari, MD discusses a case report on refractory Myasthenia Gravis flare induced by an immune check point inhibitor. This case highlights the importance of a comprehensive workup because the patient exhibited symptoms of an immune mediated Triple Overlap Syndrome of Myocarditis, Myositis and Myasthenia. ?? Poster 1188 https://lnkd.in/em__VXYB

Join our team as a full-time Breast Imaging Physician in Diagnostic Imaging. We’re seeking a skilled professional with expertise in multi-modality breast imaging and image-guided biopsies. Make a difference in breast cancer care and apply now! https://lnkd.in/ehGTf7iV

Ready, set, race for hope! Whether in downtown Tampa or participating virtually, let’s unite on November 23 to fuel cancer research at #MilesForMoffitt presented by AutoNation. Register today! https://lnkd.in/eFgDYhWu

Our President & CEO, Patrick Hwu, delivered the keynote at BioFlorida, Inc.'s #BioFL24! He highlighted Moffitt's role in advancing biotech in Florida, including breakthroughs in #CellTherapy and the #SperosFL campus under construction in Pasco County. #FloridaInnovation

Moffitt researchers are investigating a novel cancer vaccine designed to enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. This innovative approach may offer new options for improving patient outcomes in this challenging malignancy. https://lnkd.in/ek7MMd8M

Join us in congratulating Alex Jaeger for being awarded the American Lung Association's Lung Cancer Discovery Award for his research on lung cancer. Thank you for continuing to support cancer research at Moffitt Cancer Center!

Calling all Tampa Bay Buccaneers fans! Support lifesaving cancer research at Moffitt by bidding on autographed Buccaneers merchandise. Check out the items currently up for bid: Baker Mayfield autographed football Tom Brady autographed helmet Lavonte David autographed jersey Bid now through Nov 25: https://lnkd.in/e8Q8awQq

Calling all start-ups in the fight against cancer! ?? Applications for the CancerX Moonshot Accelerator are due Monday, November 18th! Now in its second year, this groundbreaking program is designed to drive digital innovations in oncology and empower startups with mentorship, training, and direct connections to leading cancer organizations. Don’t miss this last chance to join a groundbreaking program, we encourage you to apply by November 18: https://lnkd.in/gXd42i-8

Moffitt's Department of Cutaneous Oncology is looking for a full-time Medical Oncologist to join the Clinical Academician track. https://lnkd.in/eKDJkd7Q This program is highly regarded as one of the leading multidisciplinary skin cancer programs in the country, having pioneered several advancements in the field. Key contributions include the use of sentinel lymph node biopsies, adjuvant therapy for melanoma, tumor-infiltrating lymphocyte therapy for refractory melanoma, and percutaneous hepatic perfusion for advanced uveal melanoma. Apply today!

We are thrilled to welcome Melissa (Sorbello) Conner, our new chief enterprise risk officer, to Moffitt Cancer Center. In this role, she oversees our audit, compliance and risk programs. Before joining Moffitt, Conner spent more than 20 years in the financial services industry. She brings to Moffitt experience spanning cross-functional project delivery, risk management and compliance, regulatory relations and technology. Please join us in giving Melissa a warm welcome!